✦ LIBER ✦

Raltegravir: once-daily dose set to be tested in QDMRK trial

Book ID: 120842477
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816600-00029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P169 - Higher remission rates in patient

P169 - Higher remission rates in patients with once-daily dosing compared to twice-daily dosing. An analysis of compliance in the once daily vs. twice daily podium trial with mesalazine (Pentasa®) sachets

✍ B. Bokemeyer; A. Dignass; T. Stijnen; H. Veerman 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 42 KB

A controlled clinical trial of small dai

A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy

✍ A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Inv 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

54 A PHASE I/II, OPEN-LABEL, DOSE-ESCALA

54 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS

✍ A. Pietrangelo; P. Brissot; H. Bonkovsky; C. Niederau; L. Rojkjaer; R. Weitzman; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

187 A PHASE I/II, OPEN-LABEL, DOSE-ESCAL

187 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS

✍ P. Phatak; P. Brissot; M. Wurster; P.C. Adams; H.L. Bonkovsky; J. Gross; P. Malf 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Efficacy of high-dose, extended-release

Efficacy of high-dose, extended-release memantine (28 mg, once daily): Post hoc responder analysis from a randomized trial in patients with moderate to severe Alzheimer's disease

✍ Graham, Stephen; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Tocco, Mi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The Efficacy and Safety of Insulin Deglu

The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes

✍ Meneghini, L.; Atkin, S. L.; Gough, S. C. L.; Raz, I.; Blonde, L.; Shestakova, M 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 842 KB